Clinical Trials Browser

Not yet recruiting × Colonic Neoplasms × Propranolol × Clear all

NCT07549906 2026-04-24

Neoadjuvant Iparomlimab/Tuvonralimab Plus CAPEOX Versus Iparomlimab/Tuvonralimab Plus CAPEOX and Propranolol for Locally Advanced pMMR Colon Cancer: A Prospective, Single-Center, Multi-Cohort Study

Phase 2 Not yet recruiting

Gastrointestinal

Colonic Neoplasms